Update on Ozempic availability 7 November 2022 Diabetes Australia has been advised by Novo Nordisk that Ozempic will be unavailable in Australia until the end of March 2023. This is part of a worldwide shortage. It is also impacting supplies of other similar medicines including Trulicity. While we understand this may cause some concern, it is important to note that there are many other very effective diabetes medicines available in Australia for people with type 2 diabetes that contribute to excellent health outcomes. We encourage people who may be affected to make an appointment with their GP to review their diabetes management. This is an opportunity to consider other medicines, as well as to revisit other aspects of your type 2 diabetes management. There is also lots of information and support available through the National Diabetes Services Scheme to help you with your diabetes management. Click here https://www.ndss.com.au/about-diabetes/resources/ We are working with the Royal Australian College of General Practitioners and other health professional organisations to ensure health professionals have the latest information to support people living with diabetes. If you have any concerns, please contact Diabetes Australia on 1300 342 238 or via the NDSS Helpline 1800 637 700 and talk to your health care team.
Media releases 28 April 2025 New nib foundation partnership to enhance diabetes care for people living with disability A groundbreaking new partnership between Diabetes Australia and nib foundation will improve the lives of people living with both diabetes... Continue Reading
Media releases 8 April 2025 New data reveals diabetes prevalence in Australia may be 35% higher New research from the University of Sydney reveals that the number of Australians living with diabetes may be up to... Continue Reading
News 3 April 2025 Public warning: Counterfeit Ozempic pens detected in Australia The Therapeutic Goods Administration (TGA) is urging the diabetes community to remain alert following the detection of counterfeit Ozempic-labelled injection... Continue Reading